International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
The impact of the COVID-19 pandemic on influenza vaccination: A multi-year interrupted time series analysis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Turjeman Adi, Drozdinsky Genady, Leibovici Leonard
Аннотация
OBJECTIVE: To assess temporal changes in influenza vaccination coverage and evaluate differences by age and gender in the context of the COVID-19 pandemic.
METHODS: We conducted a population-based interrupted time series analysis using data from Clalit Health Services in Israel. Adults aged ≥21 years were followed over 11 influenza seasons (2014-2015 to 2024-2025). Annual vaccination rates were stratified by age group (21-40, 41-64, ≥65) and gender. Segmented linear regression assessed changes before and after the pandemic onset. Counterfactual modeling estimated expected vaccination rates in the absence of the pandemic.
RESULTS: Vaccination coverage declined from 26.2% (2014-2015) to 17.7% (2024-2025), despite a temporary rise to 28.7% in 2020-2021. Post-pandemic, rates decreased by 2.3 percentage points annually (p = 0.0013). The most pronounced drop was among adults aged ≥65, from 64.8% to 49.2%. Declines were observed across all age and gender groups. Interaction models showed no significant gender differences, but greater declines with increasing age. Counterfactual analysis estimated that 2024-2025 coverage was 5.7 percentage points lower than expected.
CONCLUSIONS: The COVID-19 pandemic was associated with a sustained decline in influenza vaccination uptake. Targeted strategies are needed to rebuild trust and restore routine immunization, especially among older adults.
METHODS: We conducted a population-based interrupted time series analysis using data from Clalit Health Services in Israel. Adults aged ≥21 years were followed over 11 influenza seasons (2014-2015 to 2024-2025). Annual vaccination rates were stratified by age group (21-40, 41-64, ≥65) and gender. Segmented linear regression assessed changes before and after the pandemic onset. Counterfactual modeling estimated expected vaccination rates in the absence of the pandemic.
RESULTS: Vaccination coverage declined from 26.2% (2014-2015) to 17.7% (2024-2025), despite a temporary rise to 28.7% in 2020-2021. Post-pandemic, rates decreased by 2.3 percentage points annually (p = 0.0013). The most pronounced drop was among adults aged ≥65, from 64.8% to 49.2%. Declines were observed across all age and gender groups. Interaction models showed no significant gender differences, but greater declines with increasing age. Counterfactual analysis estimated that 2024-2025 coverage was 5.7 percentage points lower than expected.
CONCLUSIONS: The COVID-19 pandemic was associated with a sustained decline in influenza vaccination uptake. Targeted strategies are needed to rebuild trust and restore routine immunization, especially among older adults.